March 2024 Br J Cardiol 2024;31:31 doi:10.5837/bjc.2024.012
Ishtiaq Rahman, Cristina Ruiz Segria, Jason Trevis, Sharareh Vahabi, Richard Graham, Jeet Thambyrajah, Ralph White, Andrew Goodwin, Simon Kendall, Enoch Akowuah
Introduction Timely corrective surgery for severe mitral regurgitation (MR) reduces the risk of limiting symptoms and irreversible left ventricular dysfunction.1,2 Left untreated, severe MR carries a poor prognosis. In asymptomatic patients, the estimated five-year rates of death from any cause, death from cardiac causes and adverse cardiac events (death, heart failure or new atrial fibrillation), are 22%, 14% and 33%, respectively.2 The prognosis for symptomatic patients is significantly worse, and further adversely affected by older age and comorbidities, including atrial fibrillation, pulmonary hypertension, left atrial dilatation, and re
December 2020 Br J Cardiol 2020;27:143–4 doi:10.5837/bjc.2020.040
Nicholas Cereceda-Monteoliva, Massimo Capoccia, Kwabena Mensah, Ruediger Stenz, Mario Petrou
Introduction Figure 1. Transthoracic echocardiogram appearance of quadricuspid aortic valve (QAV) Quadricuspid aortic valve (QAV) is a rare congenital anomaly1 that can present as aortic insufficiency requiring treatment in later life. We present a case of aortic regurgitation (AR) associated with a QAV, managed by aortic valve replacement and review the literature surrounding this unusual presentation. Case presentation Figure 2. Cardiac magnetic resonance appearance of QAV A 65-year-old Caucasian woman was referred with progressive effort-related breathlessness for treatment of longstanding AR. She presented with mild bipedal oedema, a regu
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits